| EARNINGS PER SHARE |
13.EARNINGS PER SHARE The following table sets forth the computation of basic and diluted earnings per share for the years indicated: | | | | | | | | | Years Ended December 31, | | | 2023 | | 2024 | | 2025 | Net income attributable to ordinary shareholders — basic | | 4,085 | | 3,048 | | 5,080 | Eliminate the dilutive effect of interest expense of convertible senior notes | | 120 | | 112 | | 107 | Net income attributable to ordinary shareholders — diluted | | 4,205 | | 3,160 | | 5,187 | Weighted average ordinary shares outstanding — basic | | 3,183,163,131 | | 3,115,130,107 | | 3,070,939,457 | Incremental weighted-average ordinary shares from assumed exercise of share options and nonvested restricted stocks using the treasury stock method | | 44,331,080 | | 36,507,943 | | 42,938,410 | Dilutive effect of convertible senior notes | | 123,927,000 | | 126,670,240 | | 133,616,230 | Weighted average ordinary shares outstanding — diluted | | 3,351,421,211 | | 3,278,308,290 | | 3,247,494,097 | Basic earnings per share | | 1.28 | | 0.98 | | 1.65 | Diluted earnings per share | | 1.25 | | 0.96 | | 1.60 |
For the years ended December 31, 2023, 2024 and 2025, the Group had securities which could potentially dilute basic earnings per share in the future, but which were excluded from the computation of diluted earnings per share as their effects would have been anti-dilutive. Such outstanding securities consist of the following at non-weighted basis: | | | | | | | | | As of December 31, | | | 2023 | | 2024 | | 2025 | Outstanding employee options and nonvested restricted stocks | | 53,132,230 | | 45,194,870 | | 10,265,860 |
|